Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

OK

August Webinar

Clinical Aspects of Eosinophilia

Wednesday, 7 August 2024

United States (Eastern): 9:00 am – 12:00 pm
Central European Time: 3:00 pm - 6:00 pm
Indian Standard Time (IST): 6:30 pm – 9:30 pm

This webinar is a project of the IES Outreach & Diversity Committee and is specifically designed for clinicians in India, but all are welcome to join!

Jointly hosted with the Indian Society of Hematology and Blood Transfusion (ISHBT) and the Post Graduate Institute of Medical Education & Research (PGIMER) – Chandigarh, India.

Our live webinars are completely free of charge, we just ask that you register in advance. Webinars are hosted on Zoom and audience members can ask questions using the Q&A feature. Real-time closed captioning is available for those with hearing impairments.

Program

Moderators: Reena Das - India; Rakhee Kar - India; PK Sasidharan - India; Pankaj Malhotra - India

Recent Updates on Myeloid and Lymphoid Neoplasms with Eosinophilia
Sa A. Wang - United States

Diagnostic Approach to Hypereosinophilia
Amy Klion - United States

Eosinophilia and Immunodeficiency and Rheumatological Disorders
Alexandra Freeman - United States

Management of Eosinophilia Focusing on Newer Agents
Marc Rothenberg - United States

Speakers & Moderators

Sa A. Wang, MD

Dr. Sa Wang is a professor of pathology and the section chief of flow cytometry in the Department of Hematopathology, The University of Texas MD Anderson Cancer Center. Dr. Wang’s clinical expertise and research interest are in hematolymphoid neoplasms including the use of histopathology, flow cytometry and molecular genetics for disease diagnosis, classification and risk stratification. Dr. Wang has published over 350 peer review articles, 33 review articles and 25 book chapters for 7 reference books, an editor for “Diagnosis of Blood and Bone Marrow Disorders” and the 4th edition of Hematopathology (in the series of Foundations in Diagnostic Pathology). Dr. Wang is an associate editor for Cytometry B Clinical Cytometry, council member, and currently the president for the International Clinical Cytometry Society (ICCS). Dr. Wang has taught or directed many CME courses and served as organizer, moderator, panelist, or session chair at various meetings and workshops sponsored by USCAP, CAP, ASCP, ICCS, IAP, AMLI, SH-EAH, and EH etc, and an invited speaker at many institutions. Dr. Wang has participated in the writing practice guidelines for acute leukemia diagnosis as a joined effort by the CAP and ASH. Dr. Wang is the session chair for Eosinophilic disorders and Mastocytosis in the International Consensus Classification (ICC) of hematolymphoid neoplasms, a member of the AML MRD and MDS flow cytometry ELN groups. Dr. Wang has obtained multiple industrial funds to study tumor biomarkers.

Amy D. Klion, MD

Amy D. Klion, MD is a Senior Investigator, head of the Human Eosinophil Section and Deputy Chief of the Laboratory of Parasitic Diseases at the NIH. Her research program includes basic and translational research related to the role of the eosinophil and eosinophil activation in disease pathogenesis. The ultimate goal of her laboratory is to develop novel diagnostic tools and treatment approaches for hypereosinophilic syndromes and other conditions associated with marked eosinophilia, including helminth infection. Dr. Klion is a Fellow of the American Society of Tropical Medicine and Hygiene and a recipient of the Society’s Bailey K. Ashford Medal. She has served on the editorial boards of Blood and the Journal of Allergy and Clinical Immunology and numerous advisory committees and expert panels related to her work on eosinophilic disorders and neglected tropical diseases. She is the author of more than 200 scholarly articles, reviews, and textbook chapters. 

Alexandra Freeman, MD

Dr. Alexandra Freeman is a pediatric infectious diseases physician at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health who focuses on the diagnosis and management of primary immunodeficiencies.  Dr. Freeman received her medical training at Georgetown University Medical School, completed her pediatric residency training at Yale New Haven Children’s hospital and her pediatric infectious diseases fellowship at Northwestern’s program in Chicago.  She then joined NIH as an attending physician, briefly focusing on pediatric HIV and then changing her focus to primary immunodeficiency.  Her primary focus is Hyper IgE syndromes, and she has been involved in the initial genetic diagnosis of multiple of these syndromes, and is recognized worldwide as an expert in the management of these patients due to her large cohorts of patients followed at NIAID.  She also directs the primary immunodeficiency clinic at NIAID in which she educates the allergy/immunology fellows in the diagnosis and management of individuals with complex primary immunodeficiencies.  Dr. Freeman has over 200 peer-reviewed journal articles, multiple book chapters and reviews, and has been a speaker in many national and international conferences on the topic of primary immunodeficiencies.

Marc Rothenberg, MD, PhD

Marc Rothenberg is the Director of Allergy and Immunology at Cincinnati Children's Hospital Medical Center, a Professor at the University of Cincinnati College of Medicine, the Founder and Director of the Cincinnati Center for Eosinophilic Disorders, the Founder and Director of the NIH’s Consortium of Eosinophilic Gastrointestinal Disease Researchers and the incumbent of the Bunning Chair of Allergy and Immunology. He has published over 500 peer review articles that have garnered >50,000 citations, an H-index of >130, and laid the foundation for therapeutics that are advancing the allergy/immunology field including the first drug approval by the FDA for eosinophilic esophagitis. He is a member of the National Academy of Medicine. He is the current President of the International Eosinophil Society (IES).

Reena Das, MD

Dr. Reena Das is the Professor and Head of the Department of Hematology at the Postgraduate Institute of Medical Education and Research (PGIMER) in Chandigarh, with over 28 years of teaching experience. She earned her MD in Pathology from PGIMER in 1992 and Dip NB (Pathology) in 1994. Specializing in the molecular genetics of nonmalignant hematological disorders, including thalassemias, hemoglobinopathies, hemolytic anemias, and inherited coagulation disorders, she is dedicated to the prevention of genetic disorders and prenatal diagnosis. Dr. Das has published 285 papers and 29 book chapters, and has received molecular training from institutions in China, India, and the UK. She leads numerous national and international research projects, including quintuple salt fortification in Punjab and noninvasive prenatal testing for beta thalassemia, with support from prestigious organizations like CHORI, Oakland, and CIRM, California.

Rakhee Kar, MD

Dr. Kar is a Professor and Head of the Department of Pathology at JIPMER in Puducherry, India, with over 18 years of experience in academics and research, specializes in haemostasis, hemoglobinopathies, flow cytometry, and hematolymphoid biopsies. With involvement in several research projects, they have authored 130 publications in peer-reviewed journals, contributed 14 book chapters, and co-authored a consensus document. Currently serving as the Editor-in-Chief of the Indian Journal of Hematology and Blood Transfusion (IJHBT) since 2023, they have also held positions as Associate Editor of the Journal of Hematology & Allied Sciences, Associate Editor of IJHBT from 2015 to 2020, and Vice-President of the Indian Society of Hematology and Blood Transfusion from 2019 to 2022. Additionally, they are the Founder Secretary of the Pondicherry chapter of ISHBT.

P. K. Sasidharan, MD

Dr. P. K. Sasidharan is the President of the Indian Society of Hematology and Blood Transfusion (ISHBT). He currently serves as an Emeritus Professor at Government Medical College, Kozhikode, and as the Academic Head at Aster MIMS Kozhikode. Dr. Sasidharan has held several prominent positions, including Professor of Medicine and Head of the Department of Medicine and Division of Hematology at Government Medical College, Kozhikode, Kerala, India. He has also served as the Dean of the Faculty of Medicine at the University of Calicut and the Chairman of the PG Board of Studies at Kerala University of Health Sciences. As a PhD research guide for the University of Calicut, he has contributed significantly to academic research. Additionally, he was the President of the Association of Physicians of India (API) Kerala State Chapter and a member of the Scientific Advisory Committee at the National Institute of Immuno-Hematology.

Pankaj Malhotra, MD, FRCP

Dr. Malhotra is a Professor and Head of the Department of Clinical Hematology and Medical Oncology at PGI, Chandigarh, is the Founder President of the Indian Myeloma Academic Group (IMAGe) and a member of the Board of Directors of the International Myeloma Society (IMS). Additionally, they serve as the Honorary President of the Chandigarh Chapter of the India Association for Parenteral and Enteral Nutrition. Among their accolades are the ICMR award for young Indian scientists at the Mayo Clinic, Rochester, USA, and a CML fellowship at Oregon Health and Science University, Portland, USA. They are a member of numerous national and international societies, including ASH, ASCO, ESMO, EHA, IDSA, IACA, IACR, API, ISHTM, NZ ISHTM, SIHAM, IAPEN, and ISA. They contribute as an expert member to the ICMR guidelines on MM, CML, AML, NHL, and BMT, as well as the ISHBT guidelines on ITP and nutritional anemias. With a prolific research career, they have published 591 papers in peer-reviewed journals as of April 2024.


Corporate Advisory Council
Platinum Member

Astra Zeneca

Gold Members

AllakosAmgenGSKSanofi Regeneron

Bronze Members

Areteia TherapeuticsBMSCelldexTakeda